Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 04 Jan 2023 for Oyster Point Pharma, Inc., €27k.
Insider track record
Disclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Jeffrey Nau: trading record in brief
Jeffrey Nau is a declared insider of Oyster Point Pharma, Inc. (chief executive), with filings sourced from SEC (Form 4). In total, 14 filings cover trades dated from 4 November 2019 to 3 January 2023.
Every open-market trade on record is a purchase: 1 purchase worth €14k, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 5 share grants and 5 option exercises.
The newest entry dates from 4 January 2023: a transaction, in Oyster Point Pharma, Inc. The last insider purchase was made public on 5 November 2019, 2,544 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Jeffrey Nau
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
2,607 shares@ US$11.709.3% of flowCommon StockSEC:0001209191-23-001084:0
8,938 shares@ US$11.2032.5% of flowCommon StockSEC:0001209191-22-060117:0
6,217 shares@ US$11.2022.6% of flowCommon StockSEC:0001209191-22-059794:0
46,700 shares0Common StockSEC:0001209191-22-002979:0
50,000 shares@ US$1.0218.1% of flowCommon StockSEC:0001209191-21-061371:0
10,000 shares@ US$1.023.5% of flowCommon StockSEC:0001209191-21-054298:0
6 of 6 declarations
